February 17, 2023 by
Lucy Gardner Carson
(FEBRUARY 17, 2023) Diego Adrianzen Herrera, M.D., assistant professor of medicine, commented to Medscape on a study of postremission therapy in patients with intermediate-risk acute myeloid leukemia (AML) that was published online in JAMA Oncology.
Read full story
at Medscape